Skip to main content

$0.065 0.001 (1.56%)

High

$0.07

Low

$0.07

Trades

2

Turnover

$1,268

Volume

19,512
30 June 2023 at 10:39am
Register to track HMD and receive email alerts.
Subject
HMD Ann: Trading Halt

HMD Ann: Positive Interim Results US Paid Pilot & 2nd Site Confirmed

HMD Ann: HeraCARE Shortlisted for Government tender in Spain

HMD Ann: Appendix 4D and Half Year Report

HMD Ann: Cleansing Prospectus

HMD Ann: HeraCARE paid pilot commences at Joondalup Health Campus

HMD Ann: Sheba Expands Pilot to include High-Risk Pregnancies

HMD Ann: Quarterly Activities & Cashflow Report

HMD Ann: Results of Meeting

HMD Ann: Change of Registered Office

HMD Ann: Update - Notice of Extraordinary General Meeting

HMD Ann: HeraCARE paid pilot commences with US-based Obstetrix Group

HMD Ann: Application for quotation of securities - HMD

HMD Ann: Application for quotation of securities - HMD

HMD Ann: Notice of Extraordinary General Meeting/Proxy Form

HMD Ann: Notification regarding unquoted securities - HMD

HMD Ann: Appendix 3G

HMD Ann: Results of Annual General Meeting

HMD Ann: Chairman's letter to shareholders

HMD Ann: Updated Investor Presentation and Webinar

HMD Ann: Pilot agreement signed with US leader Obstetrix Medical

HMD Ann: Trading Halt

HMD Ann: Appendix 2A

HMD Ann: Notice of Annual General Meeting/Proxy Form

HMD Ann: Quarterly Activities & Cashflow Report

HMD Ann: HeraCARE commercial agreement with Joondalup Health Campus

HMD Ann: Trading Halt

HMD Ann: Appendix 4G and Corporate Governance Statement

HMD Ann: Annual Report to shareholders

HMD Ann: JHC's Study Published One of Most Cited Scientific Journals

HMD Ann: Appendix 4E & Preliminary Final Report

HMD Ann: Becoming a substantial holder

HMD Ann: Appendix 2A & Cleansing Notice

HMD Ann: Israel's Largest Healthcare Provider Begins Pilot Study

HMD Ann: Proposed issue of Securities - HMD

HMD Ann: Proposed issue of Securities - HMD

HMD Ann: Completion of AUD 2.3M Placement

HMD Ann: Trading Halt

HMD Ann: Quarterly Activities & Cashflow Report

HMD Ann: Hapvida Extends Subscription on new SaaS Terms

HMD Ann: Updated HeraMED Investor Update Conference Call

HMD Ann: HeraMED Investor Update Conference Call

HMD Ann: Mayo Clinic approves Clinical Study of HeraBEAT

HMD Ann: Partnership to Launch HeraCARE & HeraBEAT with Teleperinatal

HMD Ann: Appendix 2A

HMD Ann: Release from escrow

HMD Ann: Partnership with eCare21 - Additional Information

HMD Ann: Partnership with eCare21 & functional integration completed

HMD Ann: Quarterly Activities & Cashflow Report

HMD Ann: Amended Updated Investor Presentation

Register to track HMD and receive email alerts.